Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q3 2014 · 10-Q
Revenue$0.00$0.00— vs Q3 2013 Net Income-$239.04K-$239.04KN/M vs Q3 2013 EPS Diluted$0.00$0.00— vs Q3 2013 Operating Income-$221,970N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Oct 23, 2014 · 23 d after period end